Transplantation in relation to the treatment of inherited disease.
D000686:Amyloidosis / Q000150:complications / Q000628:therapy; D016026:Bone Marrow Transplantation; D000795:Fabry Disease / Q000628:therapy; D005776:Gaucher Disease / Q000628:therapy; D030342:Genetic Diseases, Inborn / Q000150:complications / Q000628:therapy*; D006073:Gout / Q000150:complications / Q000628:therapy; D006105:Granulomatous Disease, Chronic / Q000628:therapy; D006453:Hemoglobinopathies / Q000628:therapy; D006467:Hemophilia A / Q000628:therapy; D006527:Hepatolenticular Degeneration / Q000628:therapy; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D016030:Kidney Transplantation; D007966:Leukodystrophy, Metachromatic / Q000628:therapy; D016031:Liver Transplantation; D008214:Lymphocytes; D008661:Metabolism, Inborn Errors / Q000150:complications / Q000628:therapy; D009083:Mucopolysaccharidoses / Q000628:therapy; D009394:Nephritis, Hereditary / Q000150:complications / Q000628:therapy; D009542:Niemann-Pick Diseases / Q000628:therapy; D010022:Osteopetrosis / Q000628:therapy; D010070:Oxalates / Q000652:urine; D019815:Oxalic Acid; D014180:Transplantation; D014443:Tyrosine / Q000097:blood; D014511:Uremia / Q000209:etiology / Q000628:therapy; D019896:alpha 1-Antitrypsin Deficiency
D010070:Oxalates; D014443:Tyrosine; D019815:Oxalic Acid